PREVALENCE OF HYPERTENSION IN THE PARAGUAY POPULATION
Abstract
Purpose of the study: Hypertension is noted as the leading risk factor for cardiovascular disease. The heart disease is among the leading causes of death in countries. Worldwide, the prevalence of hypertension varies between genders. Hence, the study examined the prevalence of hypertension in the Paraguay population.
Research Methodology: The study was literature based. The making of findings was based on findings from prior studies.
Findings: The study discovered that the prevalence of hypertension is rising globally owing to the aging of the population and increases in exposure to lifestyle risk factors. High blood pressure can damage the arteries by making them less elastic, thereby lowering the circulation of blood and oxygen to the heart, therefore, leading to heart disease. Untreated hypertension increases the damage to body organs and leads to organ failure and cardiovascular death and disability.
Conclusion: The study concluded that is sometimes, hypertension called the silent killer. The disease may show no symptoms and puts an individual at an increased risk for heart disease, heart failure and stroke, among other things. The cases of being obese and overweight are noted mostly to cause hypertension. Hypertension is noted as the leading risk factor for cardiovascular disease.
Recommendations: The study recommended that blood pressure becomes high as body weight increases, so people are encouraged to do exercise regularly, eat a healthy diet, lower intake of salt (sodium) in their diets and reduce alcohol consumption. It is also recommended that it is important to have enough night sleep, minimize stress and an individual to keep on monitoring blood pressure at home and have regular checkups. The health sectors in a country should develop strategies that will increase the screening of individuals to detect diseases early enough.
Keywords: Prevalence hypertension, Paraguay
References
Colafella, K. M. M., & Denton, K. M. (2018). Sex-specific differences in hypertension and associated cardiovascular disease. Nature Reviews Nephrology, 14(3), 185-201.
El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., ... & American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. (2020). Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation, 142(25), e506-e532.
Gao, Z., Chen, Z., Sun, A., & Deng, X. (2019). Gender differences in cardiovascular disease. Medicine in Novel Technology and Devices. Journal of Medicine, 198(12),761-782
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019). Obesity, kidney dysfunction and hypertension: mechanistic links. Nature reviews nephrology, 15(6), 367-385.
Kokubo, Y., Padmanabhan, S., Iwashima, Y., Yamagishi, K., & Goto, A. (2019). Gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines. Journal of Environmental Health and Preventive Medicine, 24(1), 1-11.
Malta, D., Petersen, K. S., Johnson, C., Trieu, K., Rae, S., Jefferson, K., ... & Arcand, J. (2018). High sodium intake increases blood pressure and risk of kidney disease. From the Science of Salt: A regularly updated systematic review of salt and health outcomes (August 2016 to March 2017). The Journal of Clinical Hypertension, 20(12), 1654-1665.
Mamani-Ortiz, Y., San Sebastián, M., Armaza, A. X., Luizaga, J. M., Illanes, D. E., Ferrel, M., & Mosquera, P. A. (2019). Prevalence and determinants of cardiovascular disease risk factors using the WHO STEPS approach in Argentina. BMC public health, 19(1), 1-13.
Mazloumi, E., Poorolajal, J., Sarrafzadegan, N., Roohafza, H. R., Faradmal, J., & Karami, M. (2019). Avoidable burden of cardiovascular diseases in the eastern Mediterranean region: contribution of selected risk factors for cardiovascular-related deaths. High blood pressure & cardiovascular prevention, 26(3), 227-237.
Milne-Ives, M., Lam, C., De Cock, C., Van Velthoven, M. H., & Meinert, E. (2020). Mobile apps for health behavior change in physical activity, diet, drug and alcohol use, and mental health: systematic review. JMIR mHealth and uHealth, 8(3), e17046.
Otoikhila, O. C. (2022). Age, smoking, hypertension, and aortic aneurysm: Interactions and risks. International Journal of Medicine and Public Health, 9 (4), 17-31
Sarma, S., Sockalingam, S., & Dash, S. (2021). Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications. Diabetes, Obesity and Metabolism. Journal of Medicine and Health, 9(13), 123-136.
Schott, A., Kluttig, A., Mikolajczyk, R., Greiser, K. H., Werdan, K., Sedding, D., & Nuding, S. (2022). Association of arterial stiffness and heart failure with preserved ejection fraction in the elderly population–results from the CARLA study. Journal of Human Hypertension,7(18), 1-9.
Sharman, J. E., O’Brien, E., Alpert, B., Schutte, A. E., Delles, C., Olsen, M. H., ... & Stergiou, G. (2020). Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure. Journal of hypertension, 38(1), 21-37
Soenarta, A. A., Buranakitjaroen, P., Chia, Y. C., Chen, C. H., Nailes, J., Hoshide, S., ... & Kario, K. (2020). An overview of hypertension and cardiac involvement in Asia: focus on heart failure. The Journal of Clinical Hypertension, 22(3), 423-430.
Srivaratharajah, K., & Abramson, B. L. (2019). Hypertension in menopausal: the effect and role of estrogen. Menopause, 26(4), 428-430.
Vogel, B., Acevedo, M., Appelman, Y., Merz, C. N. B., Chieffo, A., Figtree, G. A., ... & Mehran, R. (2021). The Lancet and cardiovascular disease Commission: reducing the global burden by 2030. The Lancet, 397(10292), 2385-2438.
Yildiz, M., Oktay, A. A., Stewart, M. H., Milani, R. V., Ventura, H. O., & Lavie, C. J. (2020). Left ventricular hypertrophy and hypertension. Progress in cardiovascular diseases, 63(1), 10-21.
Yuyun, M. F., Sliwa, K., Kengne, A. P., Mocumbi, A. O., & Bukhman, G. (2020). Cardiovascular diseases in sub-Saharan Africa compared to high-income countries: an epidemiological perspective. Global Heart, 15(1), 194-201
Zhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021). Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nature Reviews Cardiology, 18(11), 785-802.
